Login
Companies $IPSC
$1.64 -$0.00 (0.18%) After hours
Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

centurytx.com

What Do They Do?

Develops engineered, ready-to-use cell therapy candidates for people with diabetes, other autoimmune diseases and cancer.

How Do They Make Money?

Partners pay upfront fees and may reimburse costs or pay option fees, development and regulatory milestones, sales milestones, and royalties. Research-service revenue in the Bristol-Myers Squibb collaboration is earned as Century provides the work.

FY2025 revenue

Who Are Their Customers?

Bristol-Myers Squibb collaborates directly with Century on cell-therapy research and development and can choose to license development candidates for further development and commercialization.

Do Revenues Turn Into Profits?

No. It lost $9.6M in FY2025.

Operating income, FY2025
−16% of revenue
▲ +87% (Loss) vs FY2024 (−$138.1M, −2096%)
Net income, FY2025
−9% of revenue
▲ +92% (Loss) vs FY2024 (−$126.6M, −1921%)
Free cash flow, FY2025
−96% of revenue
▲ +5% (Loss) vs FY2024 (−$110.3M, −1674%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▲ +32% (Loss)
vs −$34.4M in Q3 FY2025

Broader disease focus The older report framed the pipeline around cancers and malignancies, while the latest adds beta-islet therapy for diabetes and programs for other autoimmune diseases alongside cancer.

Who Do They Compete With?

Competes with Gilead Sciences, Novartis, Bristol-Myers Squibb, Adicet Bio, Allogene Therapeutics, Artiva Biotherapeutics, Caribou Biosciences, Fate Therapeutics, Nkarta Therapeutics, Cabaletta Bio, Cartesian Therapeutics, Kyverna Therapeutics, Vertex Pharmaceuticals, Sana Biotechnology, CRISPR Therapeutics, CellTrans, Sernova, GentiBio, Encelin, and Seraxis

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support